Complete Filing Data
Jasper Therapeutics, Inc. reported Stockholders Equity of $4.15 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Jasper Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$75.8M | -$71.3M | -$64.5M | -$37.7M | -$30.6M | -$31.7M | |
| Operating Income Loss | -$83.9M | -$76.2M | -$68.9M | -$51.2M | -$36.8M | -$20.7M | $2.9M |
| General And Administrative Expense | $20.8M | $20.4M | $17.1M | $16.6M | $11.4M | $4.8M | |
| Research And Development Expense | $63.1M | $55.8M | $51.8M | $34.6M | $25.4M | $15.9M | |
| Operating Expenses | $83.9M | $76.2M | $68.9M | $51.2M | $36.8M | $20.7M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$552.3K | ||||||
| Nonoperating Income Expense | $8.1M | $5.0M | $4.4M | ||||
| Income Tax Expense Benefit | $38.5K | ||||||
| Interest Income Expense Net | -$246.0K | -$115.0K | -$80.0K | -$111.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$18.7M | -$26.7M | -$21.2M | -$18.6M | -$14.6M | -$13.7M | -$47.9M | -$16.1M | -$14.3M | -$11.9M | -$10.4M | -$2.2M | -$3.4M | -$8.4M | -$9.8M | -$201.2K | -$3.4M | $1.4M | -$1.0K |
| Operating Income Loss | -$19.2M | -$27.1M | -$21.8M | -$19.9M | -$16.0M | -$15.1M | -$19.4M | -$17.8M | -$13.9M | -$12.7M | -$12.0M | -$12.8M | -$10.1M | -$8.4M | -$6.3M | -$6.0M | -$327.6K | -$228.7K | -$1.0K |
| General And Administrative Expense | $4.8M | $5.9M | $5.6M | $5.4M | $4.7M | $4.8M | $4.5M | $4.5M | $4.1M | $3.7M | $3.8M | $4.6M | $2.9M | $3.3M | $1.8M | $1.5M | $327.6K | $228.7K | $1.0K |
| Research And Development Expense | $14.4M | $21.2M | $16.2M | $14.5M | $11.3M | $10.3M | $14.8M | $13.3M | $9.8M | $9.0M | $8.1M | $8.2M | $7.2M | $5.2M | $4.4M | $4.5M | |||
| Operating Expenses | $19.2M | $27.1M | $21.8M | $19.9M | $16.0M | $15.1M | $19.4M | $17.8M | $13.9M | $12.7M | $12.0M | $12.8M | $10.1M | $8.4M | $6.3M | $6.0M | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$3.6M | $5.5M | -$209.4K | -$3.4M | $1.5M | -$1.0K | |||||||||||||
| Nonoperating Income Expense | $430.0K | $353.0K | $561.0K | $1.3M | $1.4M | $1.3M | $1.8M | $1.7M | -$313.0K | ||||||||||
| Income Tax Expense Benefit | -$8.2K | -$1.2K | $57.8K | ||||||||||||||||
| Interest Income Expense Net | $51.0K | -$109.0K | -$70.0K | $9.0K | -$3.0K | -$74.0K | -$9.0K | $4.0K | $1.0K | -$111.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $4.2M | $61.7M | $78.4M | $36.0M | $69.5M | -$35.1M | -$4.7M |
| Cash And Cash Equivalents At Carrying Value | $28.7M | $71.6M | $86.9M | $38.3M | $84.7M | $19.8M | |
| Retained Earnings Accumulated Deficit | -$316.7M | -$240.9M | -$169.6M | -$105.1M | -$67.5M | -$36.8M | $2.0K |
| Liabilities Current | $13.2M | $15.2M | $12.4M | $7.1M | $8.0M | $4.0M | $111.4K |
| Liabilities | $31.6M | $18.2M | $16.5M | $12.4M | $24.1M | $14.6M | $3.6M |
| Assets Current | $34.6M | $75.8M | $88.9M | $41.7M | $87.8M | $20.7M | $1.5M |
| Assets | $35.8M | $79.9M | $94.9M | $48.4M | $93.7M | $23.4M | $101.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $29.1M | $72.1M | $87.3M | $38.7M | $85.0M | $20.2M | $27.2M |
| Liabilities And Stockholders Equity | $35.8M | $79.9M | $94.9M | $48.4M | $93.7M | $23.4M | $101.7M |
| Change In Value Of Common Stock Subject To Possible Redemption | -$3.5M | -$10.9M | |||||
| Common Stock Value | $3.0K | $2.0K | $1.0K | $4.0K | $1.0K | ||
| Restricted Cash Noncurrent | $417.0K | $417.0K | $417.0K | $417.0K | $345.0K | $345.0K | |
| Property Plant And Equipment Net | $102.0K | $1.9M | $2.7M | $3.6M | $3.7M | $693.0K | |
| Prepaid Expense And Other Assets Current | $6.0M | $4.2M | $2.1M | $2.8M | $3.1M | $247.0K | |
| Operating Lease Right Of Use Asset | $502.0K | $976.0K | $1.5M | $1.9M | $1.1M | $1.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$42.9M | -$15.3M | $48.6M | -$46.4M | $64.9M | -$7.0M | |
| Accounts Payable Current | $6.2M | $4.0M | $4.1M | $1.8M | $3.9M | $1.4M | |
| Accounts Payable And Other Accrued Liabilities Current | $5.7M | $10.1M | $7.3M | $4.4M | $3.6M | $2.6M | |
| Other Assets Noncurrent | $113.0K | $820.0K | $1.3M | $759.0K | $645.0K | $298.0K | |
| Operating Lease Liability Noncurrent | $724.0K | $1.8M | $2.8M | $2.4M | $1.6M | ||
| Operating Lease Liability Current | $1.2M | $1.1M | $972.0K | $865.0K | $505.0K | ||
| Change In Fair Value Of Earnout Liability | -$18.0K | -$5.7M | -$9.3M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$442.6K | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | $93.1M | ||||||
| Accounts Payable And Accrued Liabilities Current | $95.1K | ||||||
| Other Liabilities Noncurrent | $2.3M | $2.3M | $2.3M | $2.4M | $643.0K | ||
| Marketable Securities Noncurrent | $100.2M | ||||||
| Deferred Underwriting Fees Payable | $3.5M | ||||||
| Change In Value Of Class A Common Stock Subject To Possible Redemption | $590.7K | ||||||
| Cash Withdrawn From Trust Account To Pay For Franchise Taxes | $198.3K | ||||||
| Derivative Liabilities |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $11.6M | $23.5M | $42.2M | $83.7M | $100.3M | $113.2M | $94.1M | $110.2M | $125.2M | $47.6M | $58.8M | $68.1M | $78.6M | -$52.6M | -$44.6M | -$25.6M | -$15.1M | -$6.2M | $101.7M | $24.0K | ||
| Cash And Cash Equivalents At Carrying Value | $50.9M | $39.5M | $48.8M | $92.5M | $106.8M | $118.5M | $103.9M | $115.8M | $129.4M | $51.0M | $60.8M | $70.4M | $100.9M | $309.7K | $590.6K | $757.5K | $914.2K | $1.1M | $1.2M | |||
| Retained Earnings Accumulated Deficit | -$307.6M | -$288.8M | -$262.1M | -$216.5M | -$197.9M | -$183.3M | -$153.0M | -$135.5M | -$119.4M | -$91.9M | -$80.1M | -$69.7M | -$58.4M | -$5.1M | -$1.6M | -$442.3K | -$241.2K | $40.9K | ||||
| Liabilities Current | $21.0M | $20.5M | $12.3M | $12.5M | $10.1M | $8.9M | $11.9M | $9.0M | $7.9M | $7.4M | $6.6M | $6.0M | $9.2M | $328.9K | $180.8K | $180.3K | $258.3K | $170.9K | ||||
| Liabilities | $45.9M | $23.0M | $15.4M | $15.7M | $13.6M | $12.7M | $16.3M | $14.0M | $13.6M | $11.5M | $11.6M | $12.4M | $28.6M | $14.3M | $11.1M | $3.7M | $3.8M | $3.7M | ||||
| Assets Current | $54.6M | $43.0M | $53.2M | $94.8M | $108.7M | $120.3M | $105.2M | $118.6M | $132.5M | $52.4M | $63.3M | $73.8M | $102.4M | $422.9K | $756.8K | $963.5K | $1.2M | $1.4M | ||||
| Assets | $57.5M | $46.5M | $57.6M | $99.4M | $113.9M | $126.0M | $110.4M | $124.2M | $138.8M | $59.1M | $70.4M | $80.5M | $107.2M | $100.5M | $101.0M | $101.3M | $101.6M | $101.8M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $51.3M | $39.9M | $49.2M | $92.9M | $107.2M | $118.9M | $104.3M | $116.2M | $129.8M | $51.4M | $61.2M | $70.8M | $101.3M | $17.1M | $23.8M | $14.8M | ||||||
| Liabilities And Stockholders Equity | $57.5M | $46.5M | $57.6M | $99.4M | $113.9M | $126.0M | $110.4M | $124.2M | $138.8M | $59.1M | $70.4M | $80.5M | $107.2M | $100.5M | $101.0M | $101.3M | $101.6M | |||||
| Change In Value Of Common Stock Subject To Possible Redemption | -$3.5M | $1.4M | ||||||||||||||||||||
| Common Stock Value | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $11.0K | $11.0K | $11.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $187.00 | $150.00 | ||||||
| Restricted Cash Noncurrent | $417.0K | $417.0K | $417.0K | $417.0K | $417.0K | $417.0K | $417.0K | $417.0K | $417.0K | $417.0K | $417.0K | $417.0K | $345.0K | |||||||||
| Property Plant And Equipment Net | $1.1M | $1.3M | $1.6M | $2.1M | $2.4M | $2.5M | $2.8M | $3.1M | $3.3M | $3.8M | $4.0M | $3.5M | $3.3M | |||||||||
| Prepaid Expense And Other Assets Current | $3.7M | $3.5M | $4.4M | $2.3M | $1.9M | $1.8M | $1.4M | $2.8M | $3.1M | $1.5M | $2.5M | $3.4M | $1.5M | |||||||||
| Operating Lease Right Of Use Asset | $1.2M | $1.6M | $1.9M | $1.1M | $1.2M | $1.4M | $1.6M | $1.7M | $1.8M | $2.0M | $2.1M | $2.2M | $1.2M | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$22.8M | $31.6M | $91.2M | -$14.2M | $3.6M | |||||||||||||||||
| Accounts Payable Current | $9.2M | $8.0M | $3.0M | $3.1M | $3.0M | $2.4M | $3.3M | $1.6M | $3.8M | $3.1M | $3.0M | $1.5M | $2.2M | |||||||||
| Accounts Payable And Other Accrued Liabilities Current | $10.2M | $10.5M | $7.5M | $8.3M | $6.1M | $5.5M | $7.7M | $6.5M | $3.2M | $3.5M | $2.8M | $4.0M | $6.4M | |||||||||
| Other Assets Noncurrent | $150.0K | $192.0K | $532.0K | $1.0M | $1.2M | $1.4M | $411.0K | $445.0K | $725.0K | $543.0K | $577.0K | $611.0K | ||||||||||
| Operating Lease Liability Noncurrent | $201.0K | $755.0K | $1.0M | $1.3M | $1.6M | $2.1M | $2.3M | $2.6M | $3.0M | $3.2M | $3.4M | $2.5M | ||||||||||
| Operating Lease Liability Current | $1.7M | $2.0M | $1.8M | $1.1M | $1.0M | $1.0M | $945.0K | $917.0K | $891.0K | $840.0K | $784.0K | $521.0K | $490.0K | |||||||||
| Change In Fair Value Of Earnout Liability | -$20.0K | $20.0K | -$334.0K | -$420.0K | $764.0K | -$422.0K | -$625.0K | -$4.6M | -$6.2M | |||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$179.5K | -$155.6K | ||||||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $81.3M | $84.9M | $79.4M | $92.6M | $92.8M | $93.1M | ||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $328.9K | $180.8K | $269.5K | $172.4K | $185.4K | $96.9K | ||||||||||||||||
| Other Liabilities Noncurrent | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $707.0K | $749.0K | |||||||||||
| Marketable Securities Noncurrent | $100.1M | $100.2M | $100.3M | $100.4M | $100.4M | $100.4M | ||||||||||||||||
| Deferred Underwriting Fees Payable | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | ||||||||||||||||
| Change In Value Of Class A Common Stock Subject To Possible Redemption | ||||||||||||||||||||||
| Cash Withdrawn From Trust Account To Pay For Franchise Taxes | $138.2K | $77.3K | ||||||||||||||||||||
| Derivative Liabilities | $10.4M | $7.4M | $13.1M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$77.2M | -$62.6M | -$52.1M | -$45.9M | -$33.7M | -$18.3M |
| Net Cash Provided By Used In Investing Activities | $5.0K | -$532.0K | -$267.0K | -$576.0K | -$2.4M | $198.3K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.8M | $2.1M | -$767.0K | -$312.0K | $2.2M | $247.0K |
| Net Cash Provided By Used In Financing Activities | $34.2M | $47.9M | $101.0M | $55.0K | $101.0M | $11.3M |
| Stock Issued During Period Value Share Based Compensation | $4.1M | $1.0M | $1.2M | |||
| Share Based Compensation | $6.7M | $6.6M | $5.2M | $4.1M | $1.0M | $1.2M |
| Increase Decrease In Accounts Payable | $2.2M | -$122.0K | $2.4M | -$2.2M | $2.9M | $358.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $174.3K | |||||
| Increase Decrease In Other Noncurrent Assets | -$707.0K | -$523.0K | $584.0K | $114.0K | $347.0K | $250.0K |
| Proceeds From Stock Options Exercised | $329.0K | $388.0K | $27.0K | $235.0K | $53.0K | |
| Payments To Acquire Machinery And Equipment | $7.0K | $552.0K | $267.0K | $576.0K | $2.4M | |
| Increase Decrease In Operating Lease Liability | -$1.7M | -$973.0K | -$865.0K | -$589.0K | -$117.0K | $10.0K |
| Increase Decrease In Prepaid Expense | -$179.3K | |||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$4.4M | $2.9M | $2.8M | $836.0K | $959.0K | |
| Increase Decrease In Accrued Income Taxes Payable | -$16.2K | |||||
| Proceeds From Issuance Of Common Stock | $6.5M | $47.2M | $101.5M | $28.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$22.8M | -$15.7M | -$10.3M | -$14.2M | -$6.2M | -$232.9K | |||||||||||||
| Net Cash Provided By Used In Investing Activities | $4.0K | -$25.0K | -$26.0K | -$29.0K | -$960.0K | $77.3K | |||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $201.0K | -$218.0K | $290.0K | $269.0K | $785.0K | $6.0K | |||||||||||||
| Net Cash Provided By Used In Financing Activities | $47.3M | $101.5M | $13.0K | $10.8M | |||||||||||||||
| Stock Issued During Period Value Share Based Compensation | $1.4M | $1.8M | $2.0M | $1.5M | $1.4M | $1.4M | $1.3M | $644.0K | $1.1M | $778.0K | $195.0K | $295.0K | $327.0K | $316.0K | $456.0K | $1.0K | |||
| Share Based Compensation | $1.8M | $1.2M | $1.3M | $778.0K | $327.0K | ||||||||||||||
| Increase Decrease In Accounts Payable | -$1.0M | -$1.8M | $2.1M | -$2.5M | $83.0K | ||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$88.7K | $1.8K | $1.0K | ||||||||||||||||
| Increase Decrease In Other Noncurrent Assets | -$288.0K | $80.0K | -$34.0K | -$34.0K | |||||||||||||||
| Proceeds From Stock Options Exercised | $154.0K | $32.0K | $13.0K | $2.0K | |||||||||||||||
| Payments To Acquire Machinery And Equipment | $25.0K | $26.0K | $29.0K | $960.0K | |||||||||||||||
| Increase Decrease In Operating Lease Liability | -$315.0K | -$233.0K | -$206.0K | -$112.0K | |||||||||||||||
| Increase Decrease In Prepaid Expense | |||||||||||||||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$2.6M | -$1.7M | -$1.3M | $386.0K | |||||||||||||||
| Increase Decrease In Accrued Income Taxes Payable | $57.8K | ||||||||||||||||||
| Proceeds From Issuance Of Common Stock | $47.2M | $101.5M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.95 | -$4.89 | -$6.18 | -$10.33 | -$2.69 | -$5.17 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 1.0M | |
| Weighted Average Number Of Shares Outstanding Basic | 19.2M | 14.6M | 10.4M | 3.6M | 11.4M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 19.2M | 14.6M | 10.4M | 3.6M | 11.4M | ||
| Earnings Per Share Basic | $-3.95 | $-4.89 | $-6.18 | $-10.33 | $-2.69 | ||
| Common Stock Shares Outstanding | 28.0M | 15.0M | 11.2M | 3.8M | 37.9M | 2.8M | |
| Common Stock Shares Issued | 28.0M | 15.0M | 11.2M | 3.8M | 37.9M | 2.8M | |
| Common Stock Shares Authorized | 492.0M | 492.0M | 492.0M | 492.0M | 492.0M | 50.2M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | $10.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.13 | -$1.74 | -$1.41 | -$1.24 | -$0.97 | -$1.03 | -$4.68 | -$1.47 | -$1.62 | -$0.32 | -$0.29 | -$0.06 | -$0.69 | -$6.14 | ||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | |
| Weighted Average Number Of Shares Outstanding Basic | 16.6M | 15.3M | 15.0M | 15.0M | 15.0M | 13.3M | 10.2M | 10.9M | 8.8M | 36.6M | 36.4M | 36.3M | 5.0M | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 16.6M | 15.3M | 15.0M | 15.0M | 15.0M | 13.3M | 10.2M | 10.9M | 8.8M | 36.6M | 36.4M | 36.3M | 5.0M | |||||||
| Earnings Per Share Basic | $-1.13 | $-1.74 | $-1.41 | $-1.24 | $-0.97 | $-1.03 | $-4.68 | $-1.47 | $-1.62 | $-0.32 | $-0.29 | $-0.06 | $-0.69 | |||||||
| Common Stock Shares Outstanding | 28.0M | 16.2M | 15.0M | 15.0M | 15.1M | 15.1M | 110.9M | 110.8M | 109.4M | 38.0M | 38.0M | 37.9M | 37.8M | 736.2K | 691.8K | |||||
| Common Stock Shares Issued | 28.0M | 16.2M | 15.0M | 15.0M | 15.1M | 15.1M | 110.9M | 110.8M | 109.4M | 38.0M | 38.0M | 37.9M | 37.8M | 736.2K | 691.8K | |||||
| Common Stock Shares Authorized | 492.0M | 492.0M | 492.0M | 492.0M | 492.0M | 492.0M | 492.0M | 492.0M | 492.0M | 492.0M | 492.0M | 492.0M | 492.0M | |||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $10.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $320.8M | $302.5M | $248.0M | $141.1M | $137.0M | $1.7M | $5.0M |
| Fair Value Adjustment Of Warrants | -$8.5M | $575.0K | -$7.2M | -$500.0K | |||
| Stock Issued During Period Value Stock Options Exercised | $329.0K | $388.0K | $27.0K | $235.0K | $53.0K | ||
| Other Income | $4.4M | $13.5M | $6.2M | -$11.0M | |||
| Depreciation And Amortization | $1.1M | $1.4M | $1.1M | $975.0K | $377.0K | ||
| Stock Issued During Period Value Restricted Stock Award Gross | $10.0K | $10.0K | $10.0K | ||||
| Investment Income Interest | $1.7M | $5.1M | $5.2M | $701.0K | |||
| Stock Issued During Period Value New Issues | $4.9M | $97.0M | |||||
| Other Prepaid Expense Current | $326.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $319.1M | $312.3M | $304.4M | $300.2M | $298.2M | $296.6M | $247.1M | $245.7M | $244.6M | $139.5M | $138.8M | $137.8M | $137.0M | $10.1M | $6.6M | $5.4M | $5.2M | $5.0M | ||
| Fair Value Adjustment Of Warrants | -$2.1M | $575.0K | -$155.0K | -$845.0K | -$6.1M | $3.0M | -$5.7M | $3.2M | -$1.4M | |||||||||||
| Stock Issued During Period Value Stock Options Exercised | $9.0K | $136.0M | $154.0K | $36.0K | $320.0K | $32.0K | $1.0K | $13.0K | $13.0K | $132.0K | $68.0K | $2.0K | ||||||||
| Other Income | $1.8M | $1.7M | -$313.0K | $845.0K | $1.6M | $10.6M | $6.7M | $4.0K | -$3.5M | -$4.8M | -$3.1M | $1.7M | ||||||||
| Depreciation And Amortization | $279.0K | $500.0K | $300.0K | $288.0K | $300.0K | $300.0K | $274.0K | $216.0K | $22.0K | |||||||||||
| Stock Issued During Period Value Restricted Stock Award Gross | $1.0K | $1.0K | $6.0K | $2.0K | $2.0K | $3.0K | $3.0K | $2.0K | $3.0K | $3.0K | $3.0K | $2.0K | ||||||||
| Investment Income Interest | $342.0K | $437.0K | $624.0K | $1.3M | $1.5M | $1.4M | $1.4M | $1.4M | $259.0K | |||||||||||
| Stock Issued During Period Value New Issues | $4.9M | $5.9M | $47.2M | $40.0K | $96.9M | $25.0K | ||||||||||||||
| Other Prepaid Expense Current | $103.6K | $161.6K | $147.0K |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.